Jenny Griffith

Dose Escalation Assessment Among Targeted Immunomodulators in the Management of Inflammatory Bowel Disease

Rahel Ehrenberg, Jenny Griffith, Cindy Theigs et al. · Journal of Managed Care & Specialty Pharmacy · 2020 · 30 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective

M. Elaine Husni, Keith A. Betts, Jenny Griffith et al. · Rheumatology International · 2017 · 29 citations

Medicine, Clinical Sciences, Internal Medicine +16

Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 <scp>MOTIVATE</scp>, <scp>ADVANCE</scp> and <scp>FORTIFY</scp> clinical trials

Laurent Peyrin‐Biroulet, Subrata Ghosh, Scott D. Lee et al. · Alimentary Pharmacology & Therapeutics · 2022 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry

Dimitrios A. Pappas, Joel M. Kremer, Jenny Griffith et al. · Rheumatology and Therapy · 2017 · 21 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States

Christina A. Spivey, Jenny Griffith, Cameron M. Kaplan et al. · Rheumatology and Therapy · 2017 · 21 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16